{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:28:00Z","timestamp":1778336880588,"version":"3.51.4"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/mbc.0b013e32835b249d","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T07:40:58Z","timestamp":1353570058000},"page":"181-188","source":"Crossref","is-referenced-by-count":26,"title":["C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene"],"prefix":"10.1097","volume":"24","author":[{"given":"Deena Samir","family":"Eissa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer Mohamed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210203","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00280-011-1665-1","article-title":"Methotrexate toxicity and efficacy during the consolidation phase in paediatric acute lymphoblastic leukaemia and MTHFR polymorphisms as pharmacogenetic determinants.","volume":"68","author":"DAngelo","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1182\/blood-2006-10-054528","article-title":"Ancestry and pharmacogenetics of antileukemic drug toxicity.","volume":"109","author":"Kishi","year":"2007","journal-title":"Blood"},{"key":"R3-13-20210203","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3324\/haematol.2009.008326","article-title":"Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival.","volume":"94","author":"Ongaro","year":"2009","journal-title":"Haematologica"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/MBC.0b013e32833135e9","article-title":"Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.","volume":"21","author":"Tantawy","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R5-13-20210203","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00228-011-1046-z","article-title":"Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma.","volume":"67","author":"Kotnik","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"R6-13-20210203","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00280-011-1751-4","article-title":"The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue.","volume":"69","author":"Chiusolo","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"R7-13-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-6147(00)01675-8","article-title":"Biological and clinical implications of the MTHFR C677T polymorphism.","volume":"22","author":"Ueland","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"R8-13-20210203","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1182\/blood-2007-09-110593","article-title":"DNA variants in dihydrofolate reductase gene and outcome in childhood ALL.","volume":"111","author":"Dulucq","year":"2008","journal-title":"Blood"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.clon.2011.03.005","article-title":"Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: Association with risk for clear cell renal cell carcinoma and tumour behaviour in men.","volume":"24","author":"Safarinejad","year":"2012","journal-title":"Clin Oncol"},{"issue":"Suppl 6","key":"R10-13-20210203","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/1097-0142(19920315)69:6+<1543::AID-CNCR2820691307>3.0.CO;2-O","article-title":"Clinical applications of flow cytometry. Immunologic methods for measuring cell membrane and cytoplasmic antigens.","volume":"69","author":"Stewart","year":"1992","journal-title":"Cancer"},{"key":"R11-13-20210203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.V72.1.15.15","article-title":"Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Downs syndrome.","volume":"72","author":"Hayashi","year":"1988","journal-title":"Blood"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1756-8722-1-17","article-title":"Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.","volume":"1","author":"Mosad","year":"2008","journal-title":"J Hematol Oncol"},{"key":"R14-13-20210203","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1080\/10428190902893819","article-title":"Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.","volume":"50","author":"Kantar","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/abio.2002.5709","article-title":"Simultaneous detection of methylenetetrahydrofolate reductase gene polymorphisms, C677T and A1298C, by melting curve analysis with LightCycler.","volume":"306","author":"Nakamura","year":"2002","journal-title":"Anal Biochem"},{"key":"R16-13-20210203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03260036","article-title":"Genotyping of the MTHFR gene polymorphism, C677T in patients with leukemia by melting curve analysis.","volume":"7","author":"Deligezer","year":"2003","journal-title":"Mol Diagn"},{"key":"R17-13-20210203","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1182\/blood-2007-10-116186","article-title":"Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study.","volume":"111","author":"Pullarkat","year":"2008","journal-title":"Blood"},{"key":"R19-13-20210203","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0145-2126(01)00188-6","article-title":"CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia.","volume":"26","author":"Ravandi","year":"2002","journal-title":"Leuk Res"},{"key":"R20-13-20210203","first-page":"1285","article-title":"Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia.","volume":"85","author":"Liso","year":"2000","journal-title":"Haematologica"},{"key":"R21-13-20210203","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1182\/blood-2011-06-361410","article-title":"A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia.","volume":"118","author":"Lee","year":"2011","journal-title":"Blood"},{"key":"R22-13-20210203","first-page":"9","article-title":"MagNA Pure Compact System: purification of high-quality DNA from PBMCs, WBCs, and buffy coat.","volume":"2","author":"Baumgartner","year":"2005","journal-title":"Biochemica"},{"key":"R23-13-20210203","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2353\/jmoldx.2007.060035","article-title":"Improved real-time multiplex polymerase chain reaction detection of methylenetetrahydrofolate reductase (MTHFR) 677CT and 1298AC polymorphisms using nearest neighbor model-based probe design.","volume":"9","author":"Agarwal","year":"2007","journal-title":"J Mol Diagn"},{"key":"R24-13-20210203","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1014567800950","article-title":"Consanguinity and advanced maternal age as risk factors for reproductive losses in Alexandria, Egypt.","volume":"17","author":"Mokhtar","year":"2001","journal-title":"Eur J Epidemiol"},{"key":"R25-13-20210203","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/jmg.20.1.58","article-title":"Consanguineous matings in the Egyptian population.","volume":"20","author":"Hafez","year":"1983","journal-title":"J Med Genet"},{"key":"R26-13-20210203","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/annonc\/mdf322","article-title":"Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate.","volume":"13","author":"Chiusolo","year":"2002","journal-title":"Ann Oncol"},{"key":"R27-13-20210203","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.leukres.2007.03.028","article-title":"MTHFR polymorphisms influence on outcome and toxicity in acute lymphoblastic leukemia patients.","volume":"31","author":"Chiusolo","year":"2007","journal-title":"Leuk Res"},{"key":"R28-13-20210203","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.leu.2402428","article-title":"Polymorphisms in methylenetetrahydrofolate reductase and methotrexate sensitivity in childhood acute lymphoblastic leukemia.","volume":"16","author":"Taub","year":"2002","journal-title":"Leukemia"},{"key":"R29-13-20210203","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s10038-006-0096-z","article-title":"Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma.","volume":"52","author":"Imanishi","year":"2007","journal-title":"J Hum Genet"},{"key":"R30-13-20210203","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/MPH.0b013e318165b25d","article-title":"Influence of MTHFR and RFC1 polymorphisms on toxicities during maintenance chemotherapy for childhood acute lymphoblastic leukemia or lymphoma.","volume":"30","author":"Shimasaki","year":"2008","journal-title":"J Pediatr Hematol Oncol"},{"key":"R31-13-20210203","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1182\/blood.V98.1.231","article-title":"Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism.","volume":"98","author":"Ulrich","year":"2001","journal-title":"Blood"},{"key":"R32-13-20210203","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3324\/haematol.10587","article-title":"Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkins lymphoma patients: association with toxicity and survival.","volume":"92","author":"Gemmati","year":"2007","journal-title":"Haematologica"},{"key":"R33-13-20210203","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/aje\/kwg024","article-title":"5,10-methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview.","volume":"157","author":"Robien","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R34-13-20210203","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00280-011-1719-4","article-title":"MTHFR 677TT genotype and toxicity of methotrexate: controversial results.","volume":"68","author":"Lopez-Lopez","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"R35-13-20210203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/10245330701448479","article-title":"Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico.","volume":"12","author":"Ruiz-Arguelles","year":"2007","journal-title":"Hematology"},{"key":"R36-13-20210203","first-page":"1113","article-title":"Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia.","volume":"91","author":"Costea","year":"2006","journal-title":"Haematologica"},{"key":"R37-13-20210203","doi-asserted-by":"crossref","first-page":"12810","DOI":"10.1073\/pnas.96.22.12810","article-title":"Polymorphisms in the methylenetetrahydratofolate reductase gene are associated with susceptibility to acute leukemia in adults.","volume":"96","author":"Skibola","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-13-20210203","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/leu.2008.66","article-title":"Polymorphisms in folate-related genes: association with side effects of high-dose methotrexate in childhood acute lymphoblastic leukemia.","volume":"22","author":"Huang","year":"2008","journal-title":"Leukemia"},{"key":"R39-13-20210203","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1158\/0008-5472.CAN-04-2606","article-title":"Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.","volume":"65","author":"Aplenc","year":"2005","journal-title":"Cancer Res"},{"key":"R40-13-20210203","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00277-007-0274-x","article-title":"Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia.","volume":"86","author":"Pakakasama","year":"2007","journal-title":"Ann Hematol"},{"key":"R41-13-20210203","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.tpj.6500224","article-title":"Role of polymorphisms in MTHFR and MTHFD1 genes in the outcome of childhood acute lymphoblastic leukemia.","volume":"4","author":"Krajinovic","year":"2004","journal-title":"Pharmacogenomics J"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-201303000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T19:12:26Z","timestamp":1646421146000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-201303000-00013"}},"subtitle":["effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia"],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32835b249d","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}